1. Home
  2. PLYM vs CTKB Comparison

PLYM vs CTKB Comparison

Compare PLYM & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLYM
  • CTKB
  • Stock Information
  • Founded
  • PLYM 2011
  • CTKB 1990
  • Country
  • PLYM United States
  • CTKB United States
  • Employees
  • PLYM N/A
  • CTKB N/A
  • Industry
  • PLYM Real Estate Investment Trusts
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • PLYM Real Estate
  • CTKB Health Care
  • Exchange
  • PLYM Nasdaq
  • CTKB Nasdaq
  • Market Cap
  • PLYM 746.2M
  • CTKB 718.8M
  • IPO Year
  • PLYM 2017
  • CTKB 2021
  • Fundamental
  • Price
  • PLYM $16.44
  • CTKB $5.12
  • Analyst Decision
  • PLYM Buy
  • CTKB Strong Buy
  • Analyst Count
  • PLYM 8
  • CTKB 2
  • Target Price
  • PLYM $24.00
  • CTKB $9.25
  • AVG Volume (30 Days)
  • PLYM 295.8K
  • CTKB 760.6K
  • Earning Date
  • PLYM 02-26-2025
  • CTKB 02-27-2025
  • Dividend Yield
  • PLYM 5.84%
  • CTKB N/A
  • EPS Growth
  • PLYM N/A
  • CTKB N/A
  • EPS
  • PLYM 0.01
  • CTKB N/A
  • Revenue
  • PLYM $201,569,000.00
  • CTKB $201,210,000.00
  • Revenue This Year
  • PLYM N/A
  • CTKB $7.26
  • Revenue Next Year
  • PLYM $6.41
  • CTKB $8.20
  • P/E Ratio
  • PLYM $891.56
  • CTKB N/A
  • Revenue Growth
  • PLYM 2.64
  • CTKB 9.88
  • 52 Week Low
  • PLYM $16.20
  • CTKB $4.66
  • 52 Week High
  • PLYM $24.71
  • CTKB $9.33
  • Technical
  • Relative Strength Index (RSI)
  • PLYM 42.54
  • CTKB 37.48
  • Support Level
  • PLYM $16.20
  • CTKB $5.18
  • Resistance Level
  • PLYM $16.80
  • CTKB $5.48
  • Average True Range (ATR)
  • PLYM 0.38
  • CTKB 0.27
  • MACD
  • PLYM 0.04
  • CTKB 0.01
  • Stochastic Oscillator
  • PLYM 26.67
  • CTKB 27.85

About PLYM Plymouth Industrial REIT Inc.

Plymouth Industrial REIT Inc is a full-service, vertically integrated, self-administered, and self-managed Maryland corporation. It is focused on the acquisition, ownership, and management of single and multi-tenant Class B industrial properties, including distribution centers, warehouses, and light industrial properties, located in secondary and primary markets across the United States. The company has one reportable segment, which is Industrial properties. The majority of its property portfolio is spread across Florida, Ohio, Indiana, Tennessee, Illinois and Georgia, among others. It receives income primarily from the rental revenue through its properties.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: